Business
PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call
PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented, non-toxic silver dihydrogen citrate \n (SDC) antimicrobial, announced today that on December 14, 2017 the \n Company will file its Form 10-Q shortly after the close of the market \n and will host an investor conference call that day at 1:30pm PST (4:30pm \n EST) to review fiscal 2018 Q1 financial results.\n \n \n PURE management will also discuss the progress made to commercialize its \n two antimicrobial SDC-based food safety solutions:\n \n \n • PURE® Hard Surface disinfectant - The status of ongoing \n commercialization in restaurant chains (including Chipotle Mexican \n Grill); processors/manufacturers; and food transportation.\n \n \n • PURE Control® - The status of ongoing sales and marketing of FDA \n approved processing aid for fresh produce; the status of the USDA \n in-plant trials for use as a raw poultry processing aid.\n \n \n The Participant Dial-In Number for the conference call is 1-631-891-4304. \n Participants should dial in to the call at least five minutes before \n 1:30pm PST (4:30pm EST) on December 14, 2017. The call can also be \n accessed “live” online at http://public.viavid.com/index.php?id=127392.\n \n \n A replay of the recorded call will be available for 90 days on the \n Company’s website (http://www.purebio.com/investors/events-presentations/). \n You can also listen to a replay of the call by dialing 1-844-512-2921 (international \n participants dial 1-412-317-6671) starting December 14, 2017, at 7:30pm \n EST through December 21, 2017 at 11:59 pm EST. Please use PIN Number \n 10003983.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena -- \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, re...